David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$751M |
| 2 |
Advanced Micro Devices
AMD
|
+$751M |
| 3 |
Micron Technology
MU
|
+$426M |
| 4 |
Chipotle Mexican Grill
CMG
|
+$363M |
| 5 |
ExxonMobil
XOM
|
+$356M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$546M |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$485M |
| 3 |
VMW
VMware, Inc
VMW
|
+$393M |
| 4 |
Microsoft
MSFT
|
+$336M |
| 5 |
UnitedHealth
UNH
|
+$303M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.03% |
| 2 | Consumer Discretionary | 9.51% |
| 3 | Healthcare | 5.77% |
| 4 | Financials | 5.47% |
| 5 | Communication Services | 4.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3076
Sprout Social
SPT
$648M
| $882K | ﹤0.01% |
14,356
-16,388
| -53% | -$864K |
|
3077
iShares US Real Estate ETF
IYR
$4.67B
| $882K | ﹤0.01% |
+9,648
| New | +$790K |
|
3078
Tredegar Corp
TG
$276M
| $882K | ﹤0.01% |
163,012
+16,476
| +11% | +$81.3K |
|
3079
Enterprise Financial Services Corp
EFSC
$2.29B
| $881K | ﹤0.01% |
19,732
-1,418
| -7% | -$55.4K |
|
3080
PUT
Alnylam Pharmaceuticals
ALNY
$32.1B
| $880K | ﹤0.01% |
+4,600
| New | +$784K |
|
3081
ARKO Corp
ARKO
$524M
| $877K | ﹤0.01% |
106,343
+35,739
| +51% | +$274K |
|
|
ALEX
3082
DELISTED
Alexander & Baldwin
ALEX
| $877K | ﹤0.01% |
46,089
-59,655
| -56% | -$1.01M |
|
3083
eGain
EGAN
$198M
| $872K | ﹤0.01% |
104,733
-15,272
| -13% | -$107K |
|
|
ELME
3084
Elme Communities
ELME
$150M
| $872K | ﹤0.01% |
59,735
-71,844
| -55% | -$982K |
|
|
CMBM
3085
DELISTED
Cambium Networks
CMBM
| $872K | ﹤0.01% |
+145,258
| New | +$715K |
|
|
CANO
3086
DELISTED
Cano Health, Inc.
CANO
| $869K | ﹤0.01% |
147,993
+37,247
| +34% | +$441K |
|
3087
PUT
United Natural Foods
UNFI
$2.88B
| $868K | ﹤0.01% |
53,500
| – | – |
|
|
PLAO
3088
DELISTED
Patria Latin American Opportunity Acquisition Corp. Class A Ordinary Shares
PLAO
| $861K | ﹤0.01% |
77,604
-681,795
| -90% | -$7.52M |
|
3089
PUT
TripAdvisor
TRIP
$1.18B
| $861K | ﹤0.01% |
40,000
| – | – |
|
3090
PUT
Archer Daniels Midland
ADM
$38.2B
| $859K | ﹤0.01% |
11,900
+3,600
| +43% | +$264K |
|
3091
Bloomin' Brands
BLMN
$945M
| $858K | ﹤0.01% |
30,484
-143,966
| -83% | -$3.5M |
|
|
CPRX
3092
DELISTED
Catalyst Pharmaceutical
CPRX
| $856K | ﹤0.01% |
50,919
-101,149
| -67% | -$1.38M |
|
|
EGRX
3093
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $855K | ﹤0.01% |
163,490
+53,490
| +49% | +$528K |
|
3094
CALL
Seagate
STX
$186B
| $854K | ﹤0.01% |
10,000
-61,300
| -86% | -$4.57M |
|
3095
Vitamin Cottage Natural Grocers
NGVC
$651M
| $853K | ﹤0.01% |
53,335
+10,206
| +24% | +$149K |
|
3096
Inspired Entertainment
INSE
$158M
| $853K | ﹤0.01% |
86,316
+11,675
| +16% | +$110K |
|
3097
WisdomTree
WT
$3.66B
| $852K | ﹤0.01% |
122,990
+95,315
| +344% | +$631K |
|
3098
PUT
Digital Realty Trust
DLR
$71.2B
| $848K | ﹤0.01% |
6,300
+4,300
| +215% | +$555K |
|
3099
CALL
Vornado Realty Trust
VNO
$7.46B
| $848K | ﹤0.01% |
30,000
-14,500
| -33% | -$345K |
|
3100
Ambarella
AMBA
$3.1B
| $847K | ﹤0.01% |
+13,827
| New | +$755K |
|
Similar funds
David Shaw's Q4 2023 Portfolio in Review
As of Q4 2023, David Shaw held 4,806 positions worth $114B, up 19% from $95.8B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
David Shaw's Q4 2023 filing shows 575 new, 1,549 increased, 1,464 reduced and 527 closed positions. Its largest new stake was iShares iBoxx $ High Yield Corporate Bond ETF: 2,424,593 shares worth $188M. The largest sale was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $546M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- David Shaw's largest Q4 2023 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 2,424,593 shares worth $188M.
- David Shaw added most to Netflix in Q4 2023, an estimated $751M increase.
- David Shaw's biggest Q4 2023 reduction was Microsoft, cutting an estimated $336M.
- David Shaw fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $546M.
- David Shaw's ten largest holdings make up 12% of its $114B portfolio in Q4 2023.
- David Shaw opened 575 new positions and closed 527 in Q4 2023.
- David Shaw's portfolio value rose 19% quarter-over-quarter to $114B.
Based on D.E. Shaw & Co's 13F filing for Q4 2023, filed 14 Feb 2024.